Yang X, Ma S, Xu H et al (2023) Construction and validation of the prediction model for venous thromboembolism risk in elderly non-surgical patients in ICU. Chin Nurs Res 37(05):791–799

Google Scholar 

Trousseau A (1865) Clinique médicale de l’Hôtel-Dieu de Paris v, vol 3. JB Baillière

Ay C, Pabinger I, Cohen AT (2017) Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost 117(2):219–230

Article  PubMed  Google Scholar 

Gerotziafas GT, Mahé I, Lefkou E et al (2020) Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer. Thromb Res 191(Suppl 1):S50–s7

Article  CAS  PubMed  Google Scholar 

Key NS, Khorana AA, Kuderer NM et al (2020) Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 38(5):496–520

Article  PubMed  Google Scholar 

Farge D, Frere C, Connors JM et al (2019) 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 20(10):e566–e81

Article  PubMed  Google Scholar 

Streiff MB, Holmstrom B, Angelini D et al (2021) Cancer-Associated venous thromboembolic Disease, Version 2.2021, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw 19(10):1181–1201

PubMed  Google Scholar 

Ma J, Qin S, Wu Y et al (2019) Guidelines for the Prevention and Treatment of Tumor-related venous thromboembolism (2019 Edition). Chin J Clin Oncol 46(13):653–660

Google Scholar 

Gerotziafas GT, Taher A, Abdel-Razeq H et al (2017) A predictive score for thrombosis Associated with breast, colorectal, lung, or ovarian Cancer: the prospective COMPASS-Cancer-Associated thrombosis study. Oncologist 22(10):1222–1231

Article  CAS  PubMed  PubMed Central  Google Scholar 

PEaPVDGotRDBotCMA (CMA), Pulmonary Embolism and Pulmonary Vascular Disease Working Committee RPB, Chinese Medical Association (CMA), Disease NCGfPaToPEaPV (2018) guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism. Natl Med J China 98(14): 1060–1087

Vascular Surgery Group CSoS, Chinese Medical Association (2017) Guidelines for the diagnosis and treatment of deep vein thrombosis (Third Edition). Chin J Gen Surg 32(9):807–812

Google Scholar 

Wang Y, Ma F, Liu B et al (2020) Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model. Chin J Oncol 42(4):340–345

CAS  Google Scholar 

Wang Y, Yang K, Zhang M et al (2020) Comparison of predictive value of different risk assessment models for venous thromboembolism in elderly patients with lung cancer. Chin J Geriatr 39(4):430–434

Google Scholar 

Tan K, Liu D, Liu H, Tang X (2021) Risk prediction of venous thromboembolism associated with gynaecologic cancer on the basis of the COMPASS-CAT risk assessment model. Chin J Gen Pract 19(12):2132–2540

Google Scholar 

Zhao L (2022) Comparison of the effectiveness of COMPASS-CAT, Padua and Khorana risk assessment models in predicting venous thromboembolism in lung cancer patients. Shanxi Med Univ

Xie L, Hang L, Zhang L et al (2022) Predictive value of the modified COMPASS-CAT Assessment Model for postoperative deep vein thrombosis in patients with gastrointestinal Ma?lignancies. Syst Med 7(22):27–30

Google Scholar 

Yuting Y, Qixia X, Yingying P et al (2021) Analysis of clinical characteristics of malignant tumors complicated with venous thromboembolism and evaluation of predictive models. Chin J Gen Pract 19(5):723–6808

Google Scholar 

Du C, Yu Z, Liu Z, Lv Y (2020) Risk factors of venous thromboembolism in lung cancer patients. Clin J Med Off 48(1):5–7

CAS  Google Scholar 

Spyropoulos AC, Eldredge JB, Anand LN et al (2020) External validation of a venous thromboembolic risk score for Cancer outpatients with solid tumors: the COMPASS-CAT venous thromboembolism risk Assessment Model. Oncologist 25(7):e1083–e90

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rupa-Matysek J, Lembicz M, Rogowska EK et al (2018) Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients. Med Oncol 35(5):63

Article  PubMed  PubMed Central  Google Scholar 

Xiong W, Zhao Y, Du H et al (2021) Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer. Thromb J 19(1):95

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi Q (2023) Clinical features and predictors of venous thromboembolism complicating lung cancer. Anhui South Med Coll

Syrigos K, Grapsa D, Sangare R et al (2018) Prospective Assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for Cancer-Associated thrombosis: the observational ROADMAP-CAT study. Oncologist 23(11):1372–1381

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen AT, Katholing A, Rietbrock S et al (2017) Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost 117(1):57–65

Article  PubMed  Google Scholar 

Patell R, Rybicki L, McCrae KR, Khorana AA (2017) Predicting risk of venous thromboembolism in hospitalized cancer patients: utility of a risk assessment tool. Am J Hematol 92(6):501–507

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansfield AS, Tafur AJ, Wang CE et al (2016) Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer. J Thromb Haemost 14(9):1773–1778

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rupa-Matysek J, Gil L, Kaźmierczak M et al (2017) Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana risk score. Med Oncol 35(1):5

Article  PubMed  PubMed Central  Google Scholar 

van Es N, Franke VF, Middeldorp S et al (2017) The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer. Thromb Res 150:30–32

Article  PubMed  Google Scholar 

Verso M, Agnelli G, Barni S et al (2012) A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med 7(3):291–292

Article  PubMed  Google Scholar 

Dou F, Li H, Zhu M et al (2018) Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer. Respir Res 19(1):88

Article  PubMed  PubMed Central  Google Scholar 

van Es N, Di Nisio M, Cesarman G et al (2017) Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica 102(9):1494–1501

Article  PubMed  PubMed Central  Google Scholar 

Yan AR, Samarawickrema I, Naunton M et al (2024) Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review and meta-analysis. Thromb Res 234:120–133

Article  CAS  PubMed  Google Scholar